Market Research Logo

Generics in Indonesia


Attention: There is an updated edition available for this report.

Generics in Indonesia

Summary

Generics in Indonesia industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2012-16, and forecast to 2021). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Essential resource for top-line data and analysis covering the Indonesia generics market. Includes market size data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

For the purposes of this profile, a generic is defined as a copy of an ethical (prescription) drug formerly protected by patents that have now expired. Both unbranded generics and all branded generics are included. However, off-patent drugs that continue to be offered by the original manufacturer under the original name, and which form part of the 'generic-eligible' market, are not included.

The Indonesian generics market is expected to generate total revenues of $911m in 2016, representing a compound annual growth rate (CAGR) of 15.9% between 2012 and 2016.

Market consumption volume is forecast to increase with a CAGR of 2.1% between 2012 and 2016, to reach a total of 47.5% of total pharma volume in 2016.

The Indonesian market should continue to see strong growth as the country’s first compulsory national health insurance system, which aims to make basic care available to every citizen by 2019, was launched in January 2014.

Scope

  • Save time carrying out entry-level research by identifying the size, growth, and leading players in the generics market in Indonesia
  • Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the generics market in Indonesia
  • Leading company profiles reveal details of key generics market players’ global operations and financial performance
  • Add weight to presentations and pitches by understanding the future growth prospects of the Indonesia generics market with five year forecasts by both value and volume
Reasons to buy
  • What was the size of the Indonesia generics market by value in 2016?
  • What will be the size of the Indonesia generics market in 2021?
  • What factors are affecting the strength of competition in the Indonesia generics market?
  • How has the market performed over the last five years?
  • How large is Indonesia’s generics market in relation to its regional counterparts?


Executive Summary
Market value
Market value forecast
Market volume
Market volume forecast
Geography segmentation
Market rivalry
Market Overview
Market definition
Market analysis
Market Data
Market value
Market volume
Market Segmentation
Geography segmentation
Market Outlook
Market value forecast
Market volume forecast
Five Forces Analysis
Summary
Buyer power
Supplier power
New entrants
Threat of substitutes
Degree of rivalry
Leading Companies
PT Kalbe Farma Tbk
PT Indofarma (Persero), Tbk
PT Sanbe Farma
PT Soho Global Health
Macroeconomic Indicators
Country data
Methodology
Industry associations
Related MarketLine research
Appendix
About MarketLine
List of Tables
Table 1: Indonesia generics market value: $ billion, 2012–16(e)
Table 2: Indonesia generics market volume: % of total pharma volume, 2012–16(e)
Table 3: Indonesia generics market geography segmentation: $ billion, 2016(e)
Table 4: Indonesia generics market value forecast: $ billion, 2016–21
Table 5: Indonesia generics market volume forecast: % of total pharma volume, 2016–21
Table 6: PT Kalbe Farma Tbk: key facts
Table 7: PT Kalbe Farma Tbk: key financials ($)
Table 8: PT Kalbe Farma Tbk: key financials (IDR)
Table 9: PT Kalbe Farma Tbk: key financial ratios
Table 10: PT Indofarma (Persero), Tbk: key facts
Table 11: PT Indofarma (Persero), Tbk: key financials ($)
Table 12: PT Indofarma (Persero), Tbk: key financials (IDR)
Table 13: PT Indofarma (Persero), Tbk: key financial ratios
Table 14: PT Sanbe Farma: key facts
Table 15: PT Soho Global Health: key facts
Table 16: Indonesia size of population (million), 2012–16
Table 17: Indonesia gdp (constant 2005 prices, $ billion), 2012–16
Table 18: Indonesia gdp (current prices, $ billion), 2012–16
Table 19: Indonesia inflation, 2012–16
Table 20: Indonesia consumer price index (absolute), 2012–16
Table 21: Indonesia exchange rate, 2012–16
List Of Figures
Figure 1: Indonesia generics market value: $ billion, 2012–16(e)
Figure 2: Indonesia generics market volume: % of total pharma volume, 2012–16(e)
Figure 3: Indonesia generics market geography segmentation: % share, by value, 2016(e)
Figure 4: Indonesia generics market value forecast: $ billion, 2016–21
Figure 5: Indonesia generics market volume forecast: % of total pharma volume, 2016–21
Figure 6: Forces driving competition in the generics market in Indonesia, 2016
Figure 7: Drivers of buyer power in the generics market in Indonesia, 2016
Figure 8: Drivers of supplier power in the generics market in Indonesia, 2016
Figure 9: Factors influencing the likelihood of new entrants in the generics market in Indonesia, 2016
Figure 10: Factors influencing the threat of substitutes in the generics market in Indonesia, 2016
Figure 11: Drivers of degree of rivalry in the generics market in Indonesia, 2016
Figure 12: PT Kalbe Farma Tbk: revenues & profitability
Figure 13: PT Kalbe Farma Tbk: assets & liabilities
Figure 14: PT Indofarma (Persero), Tbk: revenues & profitability

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report